| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/02/2006 | US20060042506 Gluten biopolymers |
| 03/02/2006 | DE102005026163A1 Gegen den Marburg I Polymorphismus der Faktor VII aktivierenden Protease (FSAP) gerichtete Antikörper, ihre Herstellung und Verwendung Against the Marburg I polymorphism of the factor VII-activating protease (FSAP) Antibodies, their production and use |
| 03/02/2006 | DE102004042286A1 Self-assembling proteins with altered electronic structure, useful in biomolecular engineering, e.g. for deposition of metal clusters, are modified by incorporation of electron donors |
| 03/02/2006 | DE102004041639A1 Verfahren zur Gewinnung von biologisch aktivem humanen G-CSF aus Inclusion Bodies A process for obtaining biologically active human G-CSF from inclusion bodies |
| 03/02/2006 | CA2578361A1 Binding member towards pneumolysin |
| 03/02/2006 | CA2578136A1 Gonadotropic hormone originating in invertabrate and method of producing the same |
| 03/02/2006 | CA2577915A1 Process for obtaining recombinant prothrombin activating protease (rlopap) in monomeric form; the recombinant prothrombin activating protease (rlopap) as well as its amino acid sequence; the use of this protease as a defibrinogenase agent and the diagnosis kit for dysprothrombinemias. |
| 03/02/2006 | CA2577370A1 Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 03/02/2006 | CA2577329A1 Eph receptor fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 03/02/2006 | CA2577326A1 Selective vpac2 receptor peptide agonists |
| 03/02/2006 | CA2577010A1 Selective vpac2 receptor peptide agonists |
| 03/02/2006 | CA2576755A1 Selective vpac2 receptor peptide agonists |
| 03/02/2006 | CA2576519A1 Il-1 antagonist formulations |
| 03/02/2006 | CA2576217A1 Selective vpac2 receptor peptide agonists |
| 03/02/2006 | CA2575800A1 Optimized nucleotide sequences encoding sgp 130 |
| 03/02/2006 | CA2574507A1 Use of amphiregulin as a protective agent in acute hepatic injury |
| 03/02/2006 | CA2572938A1 Genetically modified human natural killer cell lines |
| 03/02/2006 | CA2554707A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer |
| 03/01/2006 | EP1630232A1 Optimized nucleotide sequences encoding sgp130 |
| 03/01/2006 | EP1630230A2 Streptococcus pneumoniae proteins and nucleic acids |
| 03/01/2006 | EP1630229A2 Melanoma antigens |
| 03/01/2006 | EP1630174A1 Liver x receptor alpha splicing mutant protein, gene thereof and utilization of the same |
| 03/01/2006 | EP1630173A2 Process for recovering biologically active human G-CSF from inclusion bodies |
| 03/01/2006 | EP1630172A2 A method for identification, isolation and production of antigens to a specific phathogen |
| 03/01/2006 | EP1630171A1 Streptavidin binding peptides |
| 03/01/2006 | EP1630168A2 Molecular mimetics of meningococcal B peptides |
| 03/01/2006 | EP1629849A2 Pharmaceutical compositions comprising exendins and agonists thereof |
| 03/01/2006 | EP1629280A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 4 (5-ht4) |
| 03/01/2006 | EP1629275A2 Method for the selection of epitopes for immunotherapy |
| 03/01/2006 | EP1629106A2 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-beta-PROTEINS (TGF-betas) IN CELLS |
| 03/01/2006 | EP1629104A1 Cell surface expression vector of sars virus antigen and microorganisms transformed thereby |
| 03/01/2006 | EP1629098A2 Complement inhibitors from ticks |
| 03/01/2006 | EP1629092A2 CRYSTALLOGRAPHIC STRUCTURE OF TRYPANOSOMA CRUZI PROLINE RACEMASE (TcPRACA) AND USES THEREOF |
| 03/01/2006 | EP1629091A2 Compound containing polyprotein ns3/ns4 and hcv polypeptide ns5b, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof |
| 03/01/2006 | EP1629088A2 Prostate stem cell antigen (psca) variants and subsequences thereof |
| 03/01/2006 | EP1629086A2 POLYNUCLEOTIDES ENCODING NOVEL GUANYLATE BINDING PROTEINS (GBP'S) |
| 03/01/2006 | EP1629083A2 Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests |
| 03/01/2006 | EP1629082A2 Glucose transport-related genes and uses thereof |
| 03/01/2006 | EP1629008A1 Tnf-like secreted protein |
| 03/01/2006 | EP1629007A2 Novel peptides that bind to the erythropoietin receptor |
| 03/01/2006 | EP1629006A1 Phl p 5a derivatives with reduced allergenicity and retained t-cell reactivity |
| 03/01/2006 | EP1629005A2 Enterococcus antigens |
| 03/01/2006 | EP1629004A1 Immunogenic compositions comprising venezuelan equine encephalitis virus replicon vectors and paramyxovirus protein antigens |
| 03/01/2006 | EP1629003A2 Methods for identifying inhibitors |
| 03/01/2006 | EP1628996A2 Imageable animal model of sars infection |
| 03/01/2006 | EP1628994A2 Method for identifying modulators of g protein coupled receptor signaling |
| 03/01/2006 | EP1628991A2 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 03/01/2006 | EP1628686A2 Spacer moiety for poly (ethylene glycol)-modified peptides |
| 03/01/2006 | EP1628680A2 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 03/01/2006 | EP1628675A2 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 03/01/2006 | EP1628629A2 Polynucleotides and polypeptides associated with the nf-kb pathway |
| 03/01/2006 | EP1628618A2 Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |
| 03/01/2006 | EP1545428A4 Process for decreasing aggregate levels of pegylated protein |
| 03/01/2006 | EP1485398A4 Methods of screening for compounds that modulate hormone receptor activity |
| 03/01/2006 | EP1417309A4 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof |
| 03/01/2006 | EP1341899B1 Bacterial host strains |
| 03/01/2006 | EP1305636B1 Screening method |
| 03/01/2006 | EP1305421B1 Enhanced 2-keto-l-gulonic acid production |
| 03/01/2006 | EP1206577B1 Binary encoded sequence tags |
| 03/01/2006 | EP1169465B1 Two-step immunization procedure against chlamydia infection |
| 03/01/2006 | EP1141250B1 Intein-mediated cyclization of peptides |
| 03/01/2006 | EP1105409B1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 03/01/2006 | EP1097228B1 Method of making proteins in transformed yeast cells |
| 03/01/2006 | EP1062517B1 Diagnosis of spongiform encephalopathies using prionins |
| 03/01/2006 | EP1049488B1 Method of and compositions for immunization with the pseudomonas aeruginosa v-antigen |
| 03/01/2006 | EP1049482B1 Method of producing elastin, elastin-based biomaterials and tropoelastin materials |
| 03/01/2006 | EP1038001B1 Constitutive expression of non-infectious hiv-like particles |
| 03/01/2006 | EP1021463B1 Factor g reduced amebocyte lysates for detection of bacterial endotoxins |
| 03/01/2006 | EP1017382B1 Biarylalkanoic acids as cell adhesion inhibitors |
| 03/01/2006 | EP0979241B1 (3r)-3-amino-4-carboxybutyraldehyde derivatives inhibiting the release of interleukin-1/beta |
| 03/01/2006 | EP0941315B1 Fusion proteins containing stress proteins for inducing immune responses |
| 03/01/2006 | EP0933380B1 Method of searching for physiologically active substances and process for producing the same |
| 03/01/2006 | EP0932678B1 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 03/01/2006 | EP0931148B1 Fibroblast growth factor homologs |
| 03/01/2006 | EP0920498B1 Hamster ef-1alpha transcriptional regulatory dna |
| 03/01/2006 | EP0914346B1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCalpha RECEPTOR ANTIBODIES |
| 03/01/2006 | EP0907735B1 Modulators of tissue regeneration |
| 03/01/2006 | EP0862634B2 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 03/01/2006 | EP0840750B1 Ha-2 antigenic peptide |
| 03/01/2006 | EP0786009B1 Process for bacterial production of heterologous polypeptides with disulphide bonds |
| 03/01/2006 | EP0677105B1 Allergenic proteins and peptides from dog dander and uses therefor |
| 03/01/2006 | CN1742203A Methods of screening for compounds that inhibit the biosynthesis of GPI in malaria parasites |
| 03/01/2006 | CN1742078A Method for producing target proteins by deleting or amplifying ibpA and/or ibpB gene coding for inclusion body-associated proteins |
| 03/01/2006 | CN1742020A Human protooncogene and protein encoded therein |
| 03/01/2006 | CN1742019A Process for the preparation of hypoallergenic mosaic proteins |
| 03/01/2006 | CN1741820A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/01/2006 | CN1741817A A hepatitis c virus codon optimized non-structural NS3/4A fusion gene |
| 03/01/2006 | CN1741816A Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 03/01/2006 | CN1741815A 疟疾疫苗 Malaria Vaccine |
| 03/01/2006 | CN1741814A Modified naturetic compounds, conjugates, and uses thereof |
| 03/01/2006 | CN1741813A Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing |
| 03/01/2006 | CN1741812A Modified hemoglobin and methods of making same |
| 03/01/2006 | CN1741741A Composition and method for treating lupus nephritis |
| 03/01/2006 | CN1740199A Technological process of preparing collagen peptide with starfish shell |
| 03/01/2006 | CN1740198A GLP-1 derivative |
| 03/01/2006 | CN1740197A Recombination interferon with new space conformation and enhanced effect, its preparing method and application |
| 03/01/2006 | CN1740196A Purification process and application of antigen capable of being used in diagnosis of multiple myitis/dermatomyositis |
| 03/01/2006 | CN1740195A Polypeptide gapM1 and its prepn process |
| 03/01/2006 | CN1740194A One kind of tumor relevant protein and its coding gene and application |
| 03/01/2006 | CN1740193A Non-amidated omega-conotoxin VIIA and its prepn process and application |